Chronic Osteoarthritis Clinical Trial
Official title:
Randomised, Double-blind, Double-dummy, Parallel-group Multicentre Study to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in Subjects With Moderate to Severe Pain Due to Osteoarthritis (OA) of the Knee &/or Hip Taking Oxycodone Equivalent of 20 - 80 mg/Day as Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Subjects Taking Oxycodone Prolonged Release Tablets (OxyPR) Alone.
The primary objectives are
- to demonstrate that the treatment with OXN PR tablets is non-inferior to the treatment
with OxyPR with regards to analgesic efficacy and locomotor function.
- to demonstrate that subjects with moderate to severe OA pain taking oxycodone/naloxone
prolonged release tablets have improvement in symptoms of constipation compared to
subjects taking oxycodone prolonged release tablets alone
Subjects with moderate to severe pain due to osteoarthritis (OA) will be randomised to oxycodone/naloxone prolonged release (OXN PR) or oxycodone prolonged release tablets (OxyPR) alone to demonstrate that the treatment with OXN PR tablets is non-inferior to the treatment with OxyPR with regards to analgesic efficacy and locomotor function and to demonstrate that subjects taking OXN PR have improvement in symptoms of constipation compared to subjects taking OxyPR alone. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03969654 -
ROSA Robot Used in Total Knee Replacement Post Market Study
|
N/A | |
Terminated |
NCT03970629 -
ROSA Total Knee Investigational Testing Authorization Study
|
N/A | |
Active, not recruiting |
NCT04338893 -
ROSA Total Knee Post Market Study EMEA
|
N/A |